COMPUGEN LTD(CGEN)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
CGEN Stock Analysis & AI Quality Score
AI stock analysis and institutional research for COMPUGEN LTD (CGEN), a Healthcare sector company. CGEN is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (FY 2025), COMPUGEN LTD reports quarterly revenue of $72.8M, net income of $35.3M, an operating margin of 43.0%. Top institutional holders of CGEN by reported 13-F value include SILVERARC CAPITAL MANAGEMENT,, RENAISSANCE TECHNOLOGIES, MORGAN STANLEY, based on the most recent SEC filings. CGEN trades on the Nasdaq exchange and files with the SEC under CIK 1119774. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CGEN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for COMPUGEN LTD directly from SEC EDGAR.
Revenue
FY 2025
$72.8M
Net Income
FY 2025
$35.3M
Free Cash Flow
FY 2025
$31.3M
Operating Margin
FY 2025
43.0%
Get alerted when CGEN's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for COMPUGEN LTD including:
Top Institutional Holders of CGEN
SILVERARC CAPITAL MANAGEMENT, LLC
$7.1M3,315,845 shRENAISSANCE TECHNOLOGIES LLC
$3.5M1,632,988 shMORGAN STANLEY
$2.2M1,053,229 shARK Investment Management LLC
$2.2M1,049,873 shNOMURA ASSET MANAGEMENT INTERNATIONAL INC.
$2.2M1,020,000 shTaylor Frigon Capital Management LLC
$1.8M848,043 shNORTHERN TRUST CORP
$1.4M650,868 shTWO SIGMA INVESTMENTS, LP
$1.1M521,587 shSTATE STREET CORP
$884.7K415,366 shYelin Lapidot Holdings Management Ltd.
$679.2K318,852 sh
| Fund | Value | Shares |
|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | $7.1M | 3,315,845 |
| RENAISSANCE TECHNOLOGIES LLC | $3.5M | 1,632,988 |
| MORGAN STANLEY | $2.2M | 1,053,229 |
| ARK Investment Management LLC | $2.2M | 1,049,873 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2.2M | 1,020,000 |
| Taylor Frigon Capital Management LLC | $1.8M | 848,043 |
| NORTHERN TRUST CORP | $1.4M | 650,868 |
| TWO SIGMA INVESTMENTS, LP | $1.1M | 521,587 |
| STATE STREET CORP | $884.7K | 415,366 |
| Yelin Lapidot Holdings Management Ltd. | $679.2K | 318,852 |
More Healthcare Companies
View all Healthcare →Put CGEN on your watchlist
Track score changes the day COMPUGEN LTD files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CGEN a good stock to buy?
13F Pro's AI-powered analysis of COMPUGEN LTD (CGEN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CGEN are available on the CGEN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own CGEN?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CGEN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of COMPUGEN LTD's investment landscape.